Medical Tubing and Extrusion

Medical tubing and extrusion technologies

medtronic

Medtronic reports first commercial use of Liberant thrombectomy system

By

Medtronic [WtwhTicker symbol="MDT"](NYSE: MDT)[/WtwhTicker] today announced the first commercial use of the Liberant thrombectomy system. Liberant is indicated for the removal of fresh, soft emboli or thrombi from the vessels of the peripheral arterial and venous systems. Medtronic said it expands its portfolio of treatment options for … [Read more...] about Medtronic reports first commercial use of Liberant thrombectomy system

CMS adds reimbursement for cardiac ablation in ASCs

By

The Centers for Medicare and Medicaid Services (CMS) has provided a major reimbursement update for cardiac ablation technologies. In its 2026 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System final rule, CMS added cardiac catheter ablation procedures to its ASC-covered procedures list. This … [Read more...] about CMS adds reimbursement for cardiac ablation in ASCs

CMS finalizes renal denervation coverage that benefits Medtronic, Recor

By

CMS today issued its final National Coverage Determination (NCD) on renal denervation (RDN), marking a major win for Medtronic [WtwhTicker symbol="MDT"](NYSE: MDT)[/WtwhTicker] and Recor Medical. Both companies develop their own RDN systems. Recor Medical received the first FDA nod for its Paradise ultrasound RDN (uRDN) system in November 2023. … [Read more...] about CMS finalizes renal denervation coverage that benefits Medtronic, Recor

Medtronic reports 3-year blood pressure reductions with Symplicity Spyral RDN

By

Medtronic (NYSE: MDT) today announced new long-term results from its final report of the SPYRAL HTN-ON MED trial. SPYRAL HTN-ON MED is a global, randomized, sham-controlled trial investigating the blood pressure-lowering effect and safety of renal denervation (RDN) with the radiofrequency-based Symplicity Spyral RDN system in hypertensive patients … [Read more...] about Medtronic reports 3-year blood pressure reductions with Symplicity Spyral RDN

Medtronic earns first-of-its-kind FDA labeling for Endurant stent graft

By

Medtronic (NYSE: MDT) announced today that it received new labeling approval from the FDA for its Endurant stent graft system. The new labeling adds ruptured abdominal aortic aneurysm (rAAA) clinical evidence and removes the rAAA treatment warning. This makes Medtronic the first and only company to remove the rAAA warning from stent graft … [Read more...] about Medtronic earns first-of-its-kind FDA labeling for Endurant stent graft

Medtronic launches full U.S. distribution of Neuroguard IEP carotid stent system

By

Medtronic today announced the full U.S. rollout of the Neuroguard IEP system, a carotid stent and embolic protection device. The launch follows a limited market release and builds on Medtronic’s exclusive U.S. distribution agreement with the device’s developer Contego Medical. Neuroguard IEP combines a nitinol stent, dilation balloon and … [Read more...] about Medtronic launches full U.S. distribution of Neuroguard IEP carotid stent system

Medtronic Symplicity Spyral renal denervation tech wins regulatory nod in Japan

By

Medtronic (NYSE:MDT) announced that it received regulatory approval in Japan for its Symplicity Spyral renal denervation (RDN) system. Japan's Pharmaceuticals and Medical Devices Agency (PMDA) granted approval for the blood pressure procedure for the treatment of resistant hypertension. Medtronic now plans to initiate the process to obtain … [Read more...] about Medtronic Symplicity Spyral renal denervation tech wins regulatory nod in Japan

Medtronic warns on certain left heart vent catheters

By

The FDA issued an early notice alerting customers of a warning letter issued by Medtronic for certain DLP left heart vent catheters. Medtronic's warning recommends the removal of the affected devices from where they are used or sold. Customers should identify and quarantine all unused affected product in their inventory. The company corrected the … [Read more...] about Medtronic warns on certain left heart vent catheters

Medtronic enrolls first patient in study for Onyx liquid embolic system

By

Medtronic [WtwhTicker symbol="MDT"](NYSE: MDT)[/WtwhTicker] today announced the first patient enrolled in the PELE trial of its Onyx liquid embolic system (LES). PELE (Peripheral Onyx Liquid Embolic) evaluates the safety of Onyx LES for the embolization of arterial hemorrhage in the peripheral vasculature. Dr. Christopher Stark performed the first … [Read more...] about Medtronic enrolls first patient in study for Onyx liquid embolic system

Medtronic to distribute Future Medical’s peripheral guidewires

By

Medtronic (NYSE: MDT) today announced an exclusive U.S. distribution agreement for Future Medical Design peripheral guidewires. Japan-based Future offers specialty and workhorse guidewires. The agreement includes the first 400 cm, 0.018" peripheral guidewire available in the U.S., according to a news release. Medtronic says it expands its … [Read more...] about Medtronic to distribute Future Medical’s peripheral guidewires